Home
News Open submenu
About MedNous Open submenu
Research Directory Open submenu
Contact Us Open submenu

Close submenu News

News
Appointments
Events

Close submenu About MedNous

Who We Are
Editorial Board
Editorial Policy

Close submenu Research Directory

Research Directory
Organisations
Interviewees
Terms
Topics

Close submenu Contact Us

Contact Form

Skip to main content

12 June 2025

Last updated: Tuesday 10 June 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

When is the right time for Pharma to develop stem cell technology

Monday 2 August 2010

Interviewee/Contributor

Alain Vertès

Organisation

London Business School

Organisations

ERA Consulting Group
MedNous contributing editor
Marks and Clerk LLP
Strategus
Enterome SA
Virttu Biologics Ltd
National Institute for Biological Standards and Control
Cancer Research Technology
BonelliErede
European Forum for Good Clinical Practice

Interviewees and Contributers

José Baselga
Frank Schnieders
Friedrich von Bohlen
Nicholas Adams
Philippe Pouletty
Alfred Bach
Catherine Taylor
Alexa Machikas and Elena Kfoury
Mark Throsby
Alain Vertès

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.